Categories: News

Fujifilm and Epsilon Imaging Partner to Expand Advanced Echocardiographic Analysis and Monitoring Capabilities for Synapse Cardiology

STAMFORD, Conn., March 11, 2019 /PRNewswire/ —  FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Medical Informatics solutions, has partnered with Epsilon Imaging, a revolutionary visualization and analysis software provider for cardiac diagnostic workflow, to expand the advanced analysis capabilities of Fujifilm’s advanced imaging and reporting offering, Synapse® Cardiology PACS. Epsilon Imaging’s EchoInsight can now be embedded within Fujifilm’s Synapse Cardiology PACS, this integration is designed to enhance, standardize, and streamline interpretation and reporting of echocardiography studies, and aims to transform patient management for Synapse Cardiology PACS end users. 

“Through continuous collaboration with our partners, customers, and across technologies,  Fujifilm can arm healthcare providers with the best possible tools to improve patient outcomes,” said Bill Lacy, Vice President, Medical Informatics at FUJIFILM Medical Systems U.S.A., Inc. “Our Synapse Cardiology PACS utilizes server-side rendering with a zero footprint platform to provide access to massive cardiology datasets with sub-second performance. Joining forces with Epsilon Imaging allows us to push the boundaries of our cardiology management solutions even further by offering additional diagnostic confidence, standardization and increased efficiency to our customers.”  

Synapse Cardiology PACS is Fujifilm’s next generation, secure server-side rendering technology that works within the most popular browsers while using less bandwidth throughout the enterprise. Developed with ongoing direction from cardiologists, Synapse Cardiology PACS offers capabilities and tools that help streamline image review and reporting across all cardiovascular modalities including: Adult Echocardiography, Pediatric/Fetal Echocardiography, ECG Management (Stress, Resting, Holter), NonInvasive Vascular, Nuclear Cardiology, Cardiac Catheterization, Invasive Peripheral Vascular (IPV), Electrophysiology (EP), Cardiac CT and Cardiac MR.  

EchoInsight is Epsilon Imaging’s vendor-neutral platform that provides quantitative information based on strain imaging, analysis of cardiac tissue motion and contraction, to assist echocardiography diagnostics, along with workflow-enhancing features. EchoInsight’s clinical suite of applications is designed specifically for managing a wide variety of indications across echocardiography programs. Clinical applications seamlessly integrate strain imaging, automated cardiac function measurements and trending patient data into Synapse Cardiology PACS. 

“We are excited to partner with Fujifilm to integrate EchoInsight as a strain imaging and quantification solution for Synapse Cardiology PACS customers,” said Eric Sieczka, President and CEO of Epsilon Imaging. “Fujifilm is a leader in providing innovative, best in class healthcare products to its customers. With EchoInsight embedded in Synapse Cardiology PACS, strain imaging can be easily integrated into cardiac programs and provide valuable insight into cardiac function analysis and monitoring.  Ultimately, our goal is to assist clinicians to improve the patient continuum of care with increased confidence and efficiency.”

The following suite of EchoInsight clinical applications will be integrated into Synapse Cardiology PACS for seamless, real-time clinical access: 

EchoInsight Left Ventricle features global, regional wall and chamber function analysis. The application provides longitudinal, radial and circumferential strain imaging based on view type, as well as automated volumes, EF and linear measurements based on ASE guidelines. 

EchoInsight Left Ventricle Contrast features global longitudinal strain imaging. Customized editing function tools are tailored to contrast-enhanced studies. 

EchoInsight Right Ventricle features RV free wall, regional wall and chamber function analysis. The application provides longitudinal strain imaging, automated areas, FAC, TAPSE, S’ and linear measurements based on ASE guidelines. 

EchoInsight Stress Echo provides rest-stress study comparison as well as global, regional wall and chamber function analysis. Longitudinal strain imaging is also available, and click-of-a-button wall motion scoring is based on recognized standards. 

EchoInsight Full Heart provides simultaneous analysis of up to all four-chambers including LV & RV applications, and new atrial applications. The application features longitudinal, radial and circumferential strain imaging options based on view type, and automated cardiac function measurement capabilities. 

Fujifilm is also now an EchoInsight reseller for Epsilon Imaging and can provide product quotes to customers directly.

Fujifilm will debut the integration of Synapse Cardiology PACS and EchoInsight at the American College of Cardiology’s (ACC) 68th Annual Scientific Session and Expo in New Orleans, LA, from March 16-18, 2019. Attendees are encouraged to schedule a demonstration in advance at acc.fujimed.com, and visit booth #1301 during the meeting.  

All product and company names herein may be trademarks of their registered owners. 

About Fujifilm 

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy supplies high quality, technologically advanced endoscopic imaging solutions and devices to the medical field. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.  

FUJIFILM Holdings Corporation, Tokyo, Japan brings cutting-edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2018, the company had global revenues of $23.0 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com

About Epsilon Imaging

As a provider of workflow enhancing solutions or cardiology based in Ann Arbor, Michigan, USA, Epsilon Imaging is transforming Cardiac diagnostic workflow with a vendor neutral suite of software applications designed for echocardiography. EchoInsight provides a suite of clinical applications that provide visualization and analysis with practical strain imaging for the clinical environment. Applications assist clinicians to enhance, standardize, and streamline interpretation and reporting of echo studies. Initial applications include cardio oncology and stress echo. Learn more by visiting epsilon-imaging.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/fujifilm-and-epsilon-imaging-partner-to-expand-advanced-echocardiographic-analysis-and-monitoring-capabilities-for-synapse-cardiology-300810050.html

SOURCE FUJIFILM Medical Systems U.S.A., Inc.

user

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

1 day ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago